Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: GlaxoSmithKline Consumer Healthcare (UK) Trading Limited, 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom
For the treatment of nasal congestion, perennial and allergic rhinitis (including hay fever), sinusitis.
Otrivine Adult Nasal Spray should not be used in children aged less than 12 years old.
One application in each nostril up to 3 times daily. Do not exceed 3 applications daily into each nostril.
Nasal use.
The recommended dose should not be exceeded, especially in children and the elderly.
Excessive administration of topical xylometazoline hydrochloride or accidental ingestion may cause severe dizziness, perspiration, severely lowered body temperature, headache, bradycardia, hypertension, respiratory depression, coma and convulsions. Hypertension may be followed by hypotension. Small children are more sensitive to toxicity than adults.
Appropriate supportive measures should be initiated in all individuals suspected of an overdose, and urgent symptomatic treatment under medical supervision is indicated when warranted. This would include observation of the individual for several hours.
Unopened: 24 months.
After the container is opened for the first time: 28 days.
Do not store above 25°C.
Bottle: Low density polyethylene
Cap: High density polyethylene
Spray valve and capillary: Low density polyethylene
Carton: Cardboard
Pack size: 10 ml.
Keep all medicines out of the reach of children
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
